Skip to main content
OpenTrials
Completed

NCT Number: NCT03483597

The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis

A questionnaire for this research is designed, which initiated from TSQM-II treatment satisfaction questionnaire and based on research launched by rheumatology and immunology departments of Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research is about treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for treating this disease. This research will explore the matching degree between treatment satisfaction and expectation about rheumatoid arthritis from doctors and patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Peking Union Medical College Hospital

Beijing, 100730, China

About this study

In the last decade, China has made quick progress on treatment of rheumatoid arthritis. However, the improvement of remission rate cannot fully represent needs of patients for health. To meet health demands of patients and improve their satisfaction, an efficacy evaluation system based on the outcome report of patients should be established. A questionnaire for this research is designed and mended in view of TSQM-II treatment satisfaction questionnaire and the actual situation of RA diagnosis and treatment in China. An investigation on treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for this disease is carried out based on 120 rheumatoid immunologists and 1,200 rheumatoid arthritis patients (1:10) from Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research concludes rheumatoid specialist physicians for doctor population, and persons aged over 18 for patient population who has been confirmed as RA for 6 months above, excluding patients with Chinese reading comprehension barriers or without any RA treatment. Finally, summarize and analyze the total score of satisfaction from doctors and patients, average score of doctors and patients for various medical demands, as well as the satisfaction of patients about communication and service during medical treatment.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Doctors - registered rheumatoid specialist physicians subordinated to the 12 designated hospitals Patients - aged over 18, confirming RA for more than 6 months

Exclusion criteria

Doctors - N/A Patients - with Chinese reading comprehension barriers (unable to complete the questionnaire independently), without any RA treatment

Treatment and study plan

TSQM-II

Other

Treatment Satisfaction Questionnaire for Medication (TSQM Version II) will be used in all groups

Primary outcomes

  1. Total score of patient satisfaction

    Time frame: 1 day

    Total score of patient satisfaction

Secondary outcomes

  1. Average score of patients for various treatment demands

    Time frame: 1 day

    Average score of patients for various treatment demands

  2. Average score of patients for long-term treatment demands

    Time frame: 1 day

    Average score of patients for long-term treatment demands

  3. Average score of patients for new drug demands

    Time frame: 1 day

    Average score of patients for new drug demands

  4. Total score of doctor satisfaction

    Time frame: 1 day

    Total score of doctor satisfaction

  5. Average score of doctors for various treatment demands

    Time frame: 1 day

    Average score of doctors for various treatment demands

  6. Average score of doctors for long-term treatment demands

    Time frame: 1 day

    Average score of doctors for long-term treatment demands

  7. Average score of doctors for new drug demands

    Time frame: 1 day

    Average score of doctors for new drug demands

Sponsors and collaborators

Lead sponsor

Chinese SLE Treatment And Research Group

Other

Registry information

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Mar 30, 2018
Registry last updated
Aug 31, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.